ICIS is implementing a process of rolling consultation on all of its pricing methodologies. This consultation paper is part of this formal process and covers all of the ICIS primary price points included in the caprolactam weekly publications.
The consultation asks both general questions about the suitability of the ICIS pricing methodology and questions addressing specific caprolactam market issues.
Click here to view the Caprolactam Methodology Consultation 2020
Summary and Decision
ICIS received no formal responses on this consultation. So ICIS will not be proposing any immediate changes to the methodology of the caprolactam reports. Any decision to change this methodology will be communicated to subscribers using the usual channels and with the usual notice period.
ICIS continues to welcome any feedback on its caprolactam methodology outside of the formal consultation process.
To provide further comments or feedback please contact Barbara Ortner, Head of Market Reporting: Barbara.Ortner@icis.com